Holen Sie sich die Stockscreener-App
7.7609
0.06%
0.0009
Schlusskurs vom Vortag:
$7.76
Offen:
$7.6
24-Stunden-Volumen:
3.54M
Relative Volume:
0.50
Marktkapitalisierung:
$1.53B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.345
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
-10.13%
1M Leistung:
-18.78%
6M Leistung:
-11.05%
1J Leistung:
-45.81%
1-Tages-Spanne:
$7.555
$7.955
1-Wochen-Bereich:
$7.555
$8.6256
52-Wochen-Spanne:
$6.76
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.77 | 1.53B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
227.16 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
58.01 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.45 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.60 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.15 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Hims & Hers to sell Lilly's Zepbound on its telehealth platform - Yahoo Finance
Virtual Care Market Forecasted for Major Expansion by 2031 | - openPR.com
Chronic Disease Management Market Opportunity Potential: - openPR.com
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - Yahoo Finance
(TDOC) On The My Stocks Page - Stock Traders Daily
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report? - Yahoo Finance
Future Business Opportunities in Enterprise Telemedicine - openPR
Telepsychiatry Market 2025: Sustainable Growth, Key Trends, - openPR
Telestroke Services Market to Witness Remarkable Growth with ScienceSoft, SEVARO, Teladoc Health, Inc - openPR
Global Telehealth Services Market Is Booming So Rapidly - openPR
Teladoc (TDOC) Flat As Market Sinks: What You Should Know - Yahoo Finance
Best Statistical Video-Based Mental Health Platforms Market - openPR
Teladoc's Meltdown May Not Be Over YetMinimal Growth Opportunities (NYSE:TDOC) - Seeking Alpha
Teladoc (TDOC): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
U.S. Telehealth Counseling Market Projected To Witness - openPR
North America Telemedicine Market Major Manufacturers, Trends, Demand, Share Analysis to 2028 - openPR
Teladoc Beats Investor Suit For Good On 2nd Circ. Remand - Law360
Teladoc Defeats Securities Class Suit Over Livongo Merger Again - Bloomberg Law
Digital Therapeutics Market Size, Growth Trends & Forecast - openPR
Teladoc Health president sells shares worth $33,965 By Investing.com - Investing.com South Africa
Teladoc Health president sells shares worth $79,775 By Investing.com - Investing.com South Africa
Teladoc Health president sells $69,632 in stock - Investing.com India
Teladoc Health president sells shares worth $79,775 - Investing.com India
Teladoc Health’s chief legal officer sells $92,756 in stock - Investing.com
Teladoc Health Executives Conduct Series of Stock Transactions - TradingView
Teladoc Health Executives Sell Shares - TradingView
Hinge Health is Going Public. Is It Wise? - Dealbreaker
Online Doctor Consultation Market is Estimated to Reach US 114.3 - openPR
Teladoc Health president sells shares worth $33,965 - Investing.com
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
New Empirical Research Report on Fast-track Telemedicine - openPR
Teladoc Health (TDOC): Among the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey
Unparalleled Research on Video-Based Telemedicine Platforms - openPR
Spotting Winners: Teladoc (NYSE:TDOC) And Online Marketplace Stocks In Q4 - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
BetterHelp Says Insurer Must Cover FTC Deal, Privacy Litigation - Bloomberg Law
Upcoming Opportunities in Pediatric Telehealth Solutions - openPR
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy? - Yahoo
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth - MSN
Virtual Care Market Report | Industry Trends & Future Outlook - openPR
Teladoc Expands Specialty Care Access With Carrum Health Partnership - MSN
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner - Quantisnow
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner – Company Announcement - Financial Times
Virtual Health Service Market Projected To Witness Substantial Growth 2025-2032:Teladoc Health, Amwell, Doctor - EIN News
Teladoc's Game-Changing Partnership Solves Major Healthcare Integration Challenge for 93M Members - Stock Titan
Teladoc Doubles Down on Connected Care With New Partnerships - MSN
Teladoc Doubles Down On Connected Care With New Partnerships - Barchart
Cylinder joins Teladoc Health’s Connected Care Program to expand access to virtual digestive care - TradingView
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Teladoc partners with virtual fertility, digestive care companies - Modern Healthcare
Teladoc Health Expands Connected Care Partnerships - GlobeNewswire
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
3.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):